Connection

IVAN ROSAS to Lung Injury

This is a "connection" page, showing publications IVAN ROSAS has written about Lung Injury.
Connection Strength

2.271
  1. Targeting Danger Signals to Rescue Fibrosis. Am J Respir Cell Mol Biol. 2022 05; 66(5):468-470.
    View in: PubMed
    Score: 0.690
  2. Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. Sci Rep. 2022 02 18; 12(1):2847.
    View in: PubMed
    Score: 0.680
  3. New light is shed on the enigmatic origin of the lung myofibroblast. Am J Respir Crit Care Med. 2013 Oct 01; 188(7):765-6.
    View in: PubMed
    Score: 0.381
  4. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. EBioMedicine. 2022 Dec; 86:104351.
    View in: PubMed
    Score: 0.179
  5. Objectively Measured Chronic Lung Injury?on Chest CT. Chest. 2019 12; 156(6):1149-1159.
    View in: PubMed
    Score: 0.141
  6. Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation. Am J Respir Cell Mol Biol. 2016 08; 55(2):252-63.
    View in: PubMed
    Score: 0.116
  7. TR? activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA. Nat Commun. 2024 10 07; 15(1):8672.
    View in: PubMed
    Score: 0.051
  8. Laminin a1 is a genetic modifier of TGF-?1-stimulated pulmonary fibrosis. JCI Insight. 2018 09 20; 3(18).
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.